Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm.
Saved in:
| Title: | Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. |
|---|---|
| Authors: | Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Gener-Ricos G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Almanza-Huante E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Urrutia S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2695-2706. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
